Items tagged 'EHLs'

Haemophilia treatment survey

Suzanne O'Callaghan -
20 March 2023

SUZANNE O'CALLAGHAN Suzanne O'Callaghan is HFA Policy Research and Education Manager What information does our community want about new haemophilia…

New haemophilia therapies

12 December 2022

It is an exciting time with more new haemophilia treatments likely to become available in Australia, but there have been…

Prophylaxis and tolerisation in haemophilia A

Sumit Parikh -
13 September 2022

SUMIT PARIKH Sumit Parikh is the AHCDO ABDR Senior Research Fellow The International Society for Thrombosis and Haemostasis (ISTH) reconvened…

Managing bleeds under new treatments

Suzanne O'Callaghan -
14 March 2022

SUZANNE O'CALLAGHAN Suzanne O'Callaghan is HFA Policy Research and Education Manager With new haemophilia treatments for adults and children available…

From the President

Gavin Finkelstein -
23 March 2021

GAVIN FINKELSTEIN Gavin Finkelstein is President, Haemophilia Foundation Australia COVID-19 VACCINE As the vaccine for COVID-19 becomes available around the…

From the President

Gavin Finkelstein -
14 September 2020

GAVIN FINKELSTEIN Gavin Finkelstein is President, Haemophilia Foundation Australia NEW WFH HAEMOPHILIA GUIDELINES The new World Federation of Hemophilia (WFH)…

From the President

Gavin Finkelstein -
16 December 2019

GAVIN FINKELSTEIN Gavin Finkelstein is President, Haemophilia Foundation Australia 2019 CONFERENCE It is hard to believe the Conference is…

Extended half-life product use

Sumit Parikh -
18 September 2019

SUMIT PARIKH Dr Sumit Parikh is the AHCDO ABDR Senior Research Fellow In 2018, extended half-life (EHL) recombinant factor VIII…

Congress – a nursing perspective

17 September 2018

Australian nurses at Congress Photo: Robyn Shoemark The WFH World Congress in Glasgow was attended by 11 specialist Haemophilia Nurses…

Items tagged 'EHLs'

Join the HFA community